About FDA
Percent of CBER advisory committee member positions vacant at the end of the month
Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm
Information is current as of December 31, 2012.
Fiscal Year - 2013
| Time | Target | Percent Vacant Positions |
|---|---|---|
| Oct 2012 | 10 | 6 |
| Nov 2012 | 10 | 6 |
| Dec 2012 | 10 | 6 |
| Jan 2013 | 10 | TBD |
| Feb 2013 | 10 | TBD |
| Mar 2013 | 10 | TBD |
| Apr 2013 | 10 | TBD |
| May 2013 | 10 | TBD |
| Jun 2013 | 10 | TBD |
| Jul 2013 | 10 | TBD |
| Aug 2013 | 10 | TBD |
| Sep 2013 | 10 | TBD |
FY 2013 YTD: 6%
Number of CBER advisory committee member positions vacant at the end of the month
Fiscal Year - 2013
| Time | Target | Vacant Positions |
|---|---|---|
| Oct 2012 | N/A | 4 |
| Nov 2012 | N/A | 4 |
| Dec 2012 | N/A | 4 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
Total number of CBER advisory committee member positions at the end of the month
Fiscal Year - 2013
| Time | Target | Positions |
|---|---|---|
| Oct 2012 | N/A | 71 |
| Nov 2012 | N/A | 71 |
| Dec 2012 | N/A | 71 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
